| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Cardiac assessment of early breast cancer patients 18years after treatment with cyclophosphamide-, methotrexate-, fluorouracil- or epirubicin-based chemotherapy
|
de Azambuja, Evandro
|
|
2015
|
51 |
17 |
p. 2517-2524
8 p.
|
artikel
|
| 2 |
Childhood central nervous system tumour mortality and survival in Southern and Eastern Europe (1983–2014): Gaps persist across 14 cancer registries
|
Karalexi, Maria A.
|
|
2015
|
51 |
17 |
p. 2665-2677
13 p.
|
artikel
|
| 3 |
Clinical trial spots for cancer patients by tumour type: The cancer trials portfolio at clinicaltrials.gov
|
Prasad, Vinay
|
|
2015
|
51 |
17 |
p. 2718-2723
6 p.
|
artikel
|
| 4 |
Clinical utility of KRAS status in circulating plasma DNA compared to archival tumour tissue from patients with metastatic colorectal cancer treated with anti-epidermal growth factor receptor therapy
|
Spindler, Karen-Lise Garm
|
|
2015
|
51 |
17 |
p. 2678-2685
8 p.
|
artikel
|
| 5 |
Correlation of single arm versus randomised phase 2 oncology trial characteristics with phase 3 outcome
|
Monzon, Jose G.
|
|
2015
|
51 |
17 |
p. 2501-2507
7 p.
|
artikel
|
| 6 |
CXCL14, CXCR7 expression and CXCR4 splice variant ratio associate with survival and metastases in Ewing sarcoma patients
|
Sand, L.G.L.
|
|
2015
|
51 |
17 |
p. 2624-2633
10 p.
|
artikel
|
| 7 |
Diagnosis and treatment of dermatofibrosarcoma protuberans. European consensus-based interdisciplinary guideline
|
Saiag, Philippe
|
|
2015
|
51 |
17 |
p. 2604-2608
5 p.
|
artikel
|
| 8 |
Efficacy of targeted therapies after PD-1/PD-L1 blockade in metastatic renal cell carcinoma
|
Albiges, Laurence
|
|
2015
|
51 |
17 |
p. 2580-2586
7 p.
|
artikel
|
| 9 |
18-fluorodeoxy-glucose positron emission computed tomography as predictive of response after chemoradiation in oesophageal cancer patients
|
Elimova, Elena
|
|
2015
|
51 |
17 |
p. 2545-2552
8 p.
|
artikel
|
| 10 |
High subcutaneous adipose tissue predicts the prognosis in metastatic castration-resistant prostate cancer patients in post chemotherapy setting
|
Antoun, Sami
|
|
2015
|
51 |
17 |
p. 2570-2577
8 p.
|
artikel
|
| 11 |
How should we use anti-CTLA-4 antibodies?
|
Marabelle, Aurélien
|
|
2015
|
51 |
17 |
p. 2686-2688
3 p.
|
artikel
|
| 12 |
Hypertension (HTN) as a potential biomarker of efficacy in pazopanib-treated patients with advanced non-adipocytic soft tissue sarcoma. A retrospective study based on European Organisation for Research and Treatment of Cancer (EORTC) 62043 and 62072 trials
|
Duffaud, F.
|
|
2015
|
51 |
17 |
p. 2615-2623
9 p.
|
artikel
|
| 13 |
Imatinib in advanced chordoma: A retrospective case series analysis
|
Hindi, Nadia
|
|
2015
|
51 |
17 |
p. 2609-2614
6 p.
|
artikel
|
| 14 |
Improved inter-observer agreement of an expert review panel in an oncology treatment trial – Insights from a structured interventional process
|
Nestle, Ursula
|
|
2015
|
51 |
17 |
p. 2525-2533
9 p.
|
artikel
|
| 15 |
Induction chemotherapy prior to surgery with or without postoperative radiotherapy for oral cavity cancer patients: Systematic review and meta-analysis
|
Marta, Gustavo N.
|
|
2015
|
51 |
17 |
p. 2596-2603
8 p.
|
artikel
|
| 16 |
Intensity-modulated radiotherapy prolongs the survival of patients with nasopharyngeal carcinoma compared with conventional two-dimensional radiotherapy: A 10-year experience with a large cohort and long follow-up
|
Zhang, Meng-Xia
|
|
2015
|
51 |
17 |
p. 2587-2595
9 p.
|
artikel
|
| 17 |
Intraventricular methotrexate as part of primary therapy for children with infant and/or metastatic medulloblastoma: Feasibility, acute toxicity and evidence for efficacy
|
Pompe, Raisa S.
|
|
2015
|
51 |
17 |
p. 2634-2642
9 p.
|
artikel
|
| 18 |
Long term survival with cytotoxic T lymphocyte-associated antigen 4 blockade using tremelimumab
|
Eroglu, Zeynep
|
|
2015
|
51 |
17 |
p. 2689-2697
9 p.
|
artikel
|
| 19 |
Oral single-agent chemotherapy in older patients with solid tumours: A position paper from the International Society of Geriatric Oncology (SIOG)
|
Biganzoli, L.
|
|
2015
|
51 |
17 |
p. 2491-2500
10 p.
|
artikel
|
| 20 |
Prognostic impact of immune response in resectable colorectal liver metastases treated by surgery alone or surgery with perioperative FOLFOX in the randomised EORTC study 40983
|
Tanis, Erik
|
|
2015
|
51 |
17 |
p. 2708-2717
10 p.
|
artikel
|
| 21 |
Programmed death-1 ligand 1 and 2 are highly expressed in pleomorphic carcinomas of the lung: Comparison of sarcomatous and carcinomatous areas
|
Kim, Sehui
|
|
2015
|
51 |
17 |
p. 2698-2707
10 p.
|
artikel
|
| 22 |
Recurrent antibiotic exposure may promote cancer formation – Another step in understanding the role of the human microbiota?
|
Boursi, Ben
|
|
2015
|
51 |
17 |
p. 2655-2664
10 p.
|
artikel
|
| 23 |
Single organ metastatic disease and local disease status, prognostic factors for overall survival in stage IV non-small cell lung cancer: Results from a population-based study
|
Hendriks, L.E.
|
|
2015
|
51 |
17 |
p. 2534-2544
11 p.
|
artikel
|
| 24 |
Survival of breast cancer patients with synchronous or metachronous central nervous system metastases
|
Ho, V.K.Y.
|
|
2015
|
51 |
17 |
p. 2508-2516
9 p.
|
artikel
|
| 25 |
Survival patterns in teenagers and young adults with cancer in the United Kingdom: Comparisons with younger and older age groups
|
Stark, Dan
|
|
2015
|
51 |
17 |
p. 2643-2654
12 p.
|
artikel
|
| 26 |
The influence of prior novel androgen receptor targeted therapy on the efficacy of cabazitaxel in men with metastatic castration-resistant prostate cancer
|
van Soest, R.J.
|
|
2015
|
51 |
17 |
p. 2562-2569
8 p.
|
artikel
|
| 27 |
Timing of adjuvant chemotherapy and its relation to survival among patients with stage III colon cancer
|
Bos, A.C.R.K.
|
|
2015
|
51 |
17 |
p. 2553-2561
9 p.
|
artikel
|
| 28 |
Tyrosine kinase inhibitors in renal cell cancer: Losing an empire and yet to find a role
|
Eisen, Tim
|
|
2015
|
51 |
17 |
p. 2578-2579
2 p.
|
artikel
|
Tijdschrift beschrijving